Early differential diagnosis and restorative treatment of cerebral palsy

Close metadata

Recommended articles:

Epigenetic influences and brain development. S.S. Korsakov Journal of Neurology and Psychiatry. 2023;(3):12-19

Treatment of diseases with consequences of traumatic brain injury. S.S. Korsakov Journal of Neurology and Psychiatry. 2023;(3):26-33

Rehabilitation’s possibility of the patients with severe Parkinson’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2023;(3):56-60

Multimodal technology in the correction of post-stroke motor disorders. S.S. Korsakov Journal of Neurology and Psychiatry. 2023;(3-2):58-67

Effectiveness of rehabilitation with virtual reality and biofeedback in recovery of hand function after stroke. S.S. Korsakov Journal of Neurology and Psychiatry. 2023;(3-2):68-75

Features of treatment and rehabilitation of COVID-19 patients with ischemic stroke. S.S. Korsakov Journal of Neurology and Psychiatry. 2023;(3-2):76-84

Optimizing patient preparation prior to cardiac surgery. Russian Journal of Cardiology and Cardiovascular Surgery. 2023;(2):171-177

Predicting the results of rehabilitation treatment of patients with acute myocardial infarction who underwent coronary artery stenting: focus on the rehabilitation potential. Problems of Balneology, Physiotherapy and Exercise Therapy. 2023;(1):27-36

Modern view on upper limb physical rehabilitation after stroke. Literature review. Problems of Balneology, Physiotherapy and Exercise Therapy. 2023;(1):42-53

Comprehensive analysis of the efficacy of personalized rehabilitation programs in patients with breast cancer. Problems of Balneology, Physiotherapy and Exercise Therapy. 2023;(2):31-38

The article is devoted to an urgent problem of modern neurology — early diagnosis and complex restorative treatment of cerebral palsy (cerebral palsy). Etiological factors and pathogenetic aspects of the formation of various forms of cerebral palsy are considered in detail, as well as modern possibilities of differential diagnosis in children of the first years of life of cerebral palsy and a wide range of pathological conditions (somatic, endocrine, hereditary-conditioned, including hereditary-metabolic and neuromuscular diseases). The leading directions of complex rehabilitation of cerebral palsy are widely presented, taking into account modern standards and clinical recommendations. The high efficacy of the drug Cortexin has been shown, due to its positive multimodal action (stimulation of the processes of neuropreparation, neuroprotection, neuroplasticity) in the treatment of motor, cognitive and autonomic disorders in children with perinatal lesions of the central nervous system and cerebral palsy.

Keywords:

cerebral palsy

Cortexin

differential diagnosis

rehabilitation

hereditary diseases

Authors:

S.A. Nemkova

Pirogov Russian National Research Medical University

ORCID: 0000-0002-9679-9640

V.G. Boldyrev

Pirogov Russian National Research Medical University

ORCID: 0000-0002-3323-0537

Received:

10.11.2023

Accepted:

13.11.2023

List of references:

Rossiiskii statisticheskii ezhegodnik: statisticheskii sbornik. M.: Federal’naya sluzhba gosudarstvennoi statistiki. 2021. (In Russ.).
Baranov AA, Al’bitskii VYu, Modestov AA, et al. Russia incidence of child population (results of comprehensive medical and statistical research). Zdravookhranenie Rossiiskoi Federatsii. 2012;5:21-26. (In Russ.).
Federalnye klinicheskie rekomendatsii po detskoj nevrologii. Pod red. Guzevoi V.I. OOO «Valetudo»; 2023. (In Russ.).
Semenova KA. Vosstanovitel’noe lechenie detei s perinatal’nym porazheniem nervnoi sistemy i detskim tserebral’nym paralichom. M.: Kodeks; 2007. (In Russ.).
Nemkova SA. Modern principles of complex diagnostics and rehabilitation of perinatal lesions of the nervous system and their consequences. Zhurnal Nevrologii i Psikhiatrii im. S.S. Korsakova. 2017;117(3):40-49. (In Russ.). https://doi.org/10.17116/jnevro20171173140-49
Badalyan LO, Zhurba LT, Timonina OV. Detskie tserebral’nye paralichi. Kiev: Zdorov’e; 1988. (In Russ.).
Barashnev YuI. Perinatal’naya nevrologiya. M.: Triada-X; 2001. (In Russ.).
Nemkova SA. Detskii tserebral’nyi paralich: sovremennye tekhnologii v kompleksnoi diagnostike i reabilitatsii kognitivnykh rasstroistv. M.: Medpraktika-M; 2013. (In Russ.).
Zavadenko NN, Nemkova SA. Narusheniya razvitiya i kognitivnye disfunktsii u detei s zabolevaniyami nervnoi sistemy. MedPressInform; 2016. (In Russ.).
Skvortsov IA. Nevrologiya razvitiya. M.: Littera; 2008. (In Russ.).
Kurinczuk JJ, White-Koning M, Badawi N. Epidemiology of neonatal encephalopathy and hypoxic-ischemic encephalopathy. Early Hum Dev. 2010;86(6):239-338. https://doi.org/10.1016/j.earlhumdev.2010.05.010
Lee AC, Mullany LC, Tielsch J, et al. Incidence of and risk factors for neonatal respiratory depression and encephalopathy in rural Sarlahi, Nepal. Pediatrics. 2011;128(4):915-924. https://doi.org/10.1542/peds.2010-3590
Bombardirova EP, Yatsyk GV. Perinatal’nye porazheniya tsentral’noi nervnoi sistemy u novorozhdennykh. Izbrannye lektsii po pediatrii. Pod red. Baranova A.A., Shilyaeva R.R., Kaganova B.S. M.: Dinastiya; 2005. (In Russ.).
Volpe JJ. Neurology of the Newborn. Elsevier Sauders, Philadelphia. 2008.
Klassifikatsiya perinatal’nykh porazhenii nervnoi sistemy i ikh posledstvii u detei pervogo goda zhizni. Metodicheskie rekomendatsii. Pod red. Volodina N.N. M.: VUNMTs;. 2006. (In Russ.).
Pal’chik AB, Shabalov NP. Gipoksicheski-ishemicheskaya entsefalopatiya novorozhdennykh. M.: MEDpress-inform; 2006. (In Russ.).
Dem’yanova TG, Grigor’yants LYa, Avdeeva TG, Rumyantsev AG. Nablyudenie za glubokonedonoshennymi det’mi na pervom godu zhizni. M.: Medpraktika-M; 2006. (In Russ.).
Zavadenko NN, Efimov MS, Zavadenko AN, et al. Disorders of mental development in preterm infants with low and extremely low birth weight infants. Pediatriya. 2015;94(5):143-149. (In Russ.).
Marret S. Physiopathology of periventricular leucomalacia. Rev Méd Brux. 2003;24(5):416-419.
Stephens BE, Vohr BR. Neurodevelopmental Outcome of the Premature Infant. Ped Clin North Am. 2009;56(3):631-646. https://doi.org/10.1016/j.pcl.2009.03.005
Vnutrizheludochkovye krovoizliyaniya, postgemorragicheskaya gidrotsefaliya u novorozhdennykh detei. Printsipy okazaniya meditsinskoi pomoshchi. Metodicheskie rekomendatsii pod red. Volodina N.N., Gorelysheva S.K., Popova V.E. M.: Soyuz Pediatrov Rossii; 2014. (In Russ.).
Pal’chik AB, Shabalov NP. Toksicheskie entsefalopatii novorozhdennykh. M.: MEDpressInform; 2012. (In Russ.).
Aikardi Zh, Baks M, Gillberg K. Zabolevaniya nervnoi sistemy u detei. Per. s angl. pod red. Skoromtsa A.A. M.: Izd-vo Panfilova, BINOM; 2013. (In Russ.).
Prityko AG, Chebanenko NV, Sokolov PL, et al. Genetic Aspects of Pathogenesis of Congenital Spastic Cerebral Paralysis. Acta Biomedica Scientifica. 2019;4(3):28-39. (In Russ.). https://doi.org/10.29413/ABS.2019-4.3.4
Bruun TUJ, DesRoches CL, Wilson D, et al. Prospective cohort study for identification of underlying genetic causes in neonatal encephalopathy using whole-exome sequencing. Genet Med. 2018;20(5):486-494. https://doi.org/10.1038/gim.2017.129
Lynex CN, Carr IM, Leek JP, et al. Homozygosity for a missense mutation in the 67 kDa isoform of glutamate decarboxylase in a family with autosomal recessive spastic cerebral palsy: parallels with Stiff-Person Syndrome and other movement disorders. BMC Neurol. 2004;4(1):20. https://doi.org/10.1186/1471-2377-4-20
Lerer I, Sagi M, Meiner V, et al. Deletion of the ANKRD15 gene at 9p24.3 causes parent-of-origin-dependent inheritance of familial cerebral palsy. Hum Mol Genet. 2005;14(24):3911-3920. https://doi.org/10.1093/hmg/ddi415
Moreno-De-Luca A, Helmers SL, Mao H, et al. Adaptor protein complex-4 (AP4) deficiency causes a novel autosomal recessive cerebral palsy syndrome with microcephaly and intellectual disability. J Med Genet. 2011;48(2):141-144. https://doi.org/10.1136/jmg.2010.082263
McMichael G, Bainbridge MN, Haan E, et al. Whole-exome sequencing points to considerable genetic heterogeneity of cerebral palsy. Mol Psychiatry. 2015;20(2):176-182. https://doi.org/10.1038/mp.2014.189
Tollanes MC, Wilcox AJ, Lie RT, Moster D. Familial risk of cerebral palsy: population based cohort study. BMJ. 2014;349(67):23-29. https://doi.org/10.1136/bmj.g4294
Lien E, Andersen G, Bao Y, et al. Genes determining the severity of cerebral palsy: the role of single nucleotide polymorphisms on the amount and structure of apolipoprotein E. Acta Paediatr. 2015;104(7):701-706. https://doi.org/10.1111/apa.12983
Ebrahimi-Fakhari D, Behne R, Davies AK, Hirst J. AP-4-associated hereditary spastic paraplegia. In: Adam M.P., Ardinger H.H., Pagon R.A., et al. (eds.). GeneReviews. Seattle (WA): University of Washington; 1993-2019.
Rajatileka S, Odd D, Robinson MT, et al. Variants of the EAAT2 glutamate transporter gene promoter are associated with cerebral palsy in preterm infants. Mol Neurobiol. 2018;55(3):2013-2024. https://doi.org/10.1007/s12035-017-0462-1
Svedin P, Hagberg H, Savman K, et al. Matrix metalloproteinase-9 gene knock-out protects the immature brain after cerebral hypoxia-ischemia. J Neurosci. 2007;27(7):1511-1518. https://doi.org/10.1523/JNEUROSCI.4391-06.2007
MacLennan AH, Thompson SC, Gecz J. Cerebral palsy: causes, pathways, and the role of genetic variants. Am J Obstet Gynecol. 2015;213(6):779-788. https://doi.org/10.1016/j.ajog.2015.05.034
Nemkova SA. Cerebral Palsy: early diagnosis and rehabilitation treatment. Lechashchii Vrach. 2016;5:24-29. (In Russ.).
Scherzer L. Early Diagnosis and therapy in cerebral palsy. New York: Marcel Dekker Inc; 1990.
Klinicheskaya detskaya nevrologiya: rukovodstvo dlya vrachei. Pod red. Petrukhina A.S. M.: Meditsina; 2008. (In Russ.).
Fenichel DzhM. Pediatricheskaya nevrologiya: osnovy klinicheskoi diagnostiki. M.: Meditsina; 2004. (In Russ.).
Barashnev YuI, Bakharev VA, Novikov PV. Diagnosis and treatment of congenital and hereditary diseases in children. M.: Triad-H; 2004. (In Russ.).
Temin PA, Kazantseva LZ. Nasledstvennye narusheniya nervno psi khicheskogo razvitiya detei. M.: Meditsina; 2001. (In Russ.).
Weissbach A, Pauly MG, Herzog R, et al. Relationship of Genotype, Phenotype, and Treatment in Dopa-Responsive Dystonia: MDS Gene Review. Mov Disord. 2022;37(2):237-252. https://doi.org/10.1002/mds.28874
Yablonskaya MI, Novikov PV, Agapov EG, et al. Specific features of the clinical and laboratory diagnosis of Lesch—Nyhan syndrome and current therapy options. Rossiiskii Vestnik Perinatologii i Pediatrii. 2015;4:57-62. (In Russ.).
Prygunova TM, Radaeva TM, Stepanova EYu, et al. «Sluggish child» syndrome: significance for the differential diagnosis of hereditary metabolic diseases and degenerative lesions of the nervous system. Voprosy Sovremennoi Pediatrii. 2015;14(5):586-590. (In Russ.). https://doi.org/10.15690/vsp.v14i5.1444
Schon K, Oscroft N. Genotype, extrapyramidal features, and severity of variant ataxia-telangiectasia. Ann Neurol. 2019;85(2):170-180. https://doi.org/10.1002/ana.25394
Wen Y, Wang J, Zhang Q, et al. The genetic and clinical characteristics of aromatic L-amino acid decarboxylase deficiency in mainland China. J Hum Genet. 2020;65(7):759-769. https://doi.org/10.1038/s10038-020-0770-6
Pearson TS, Gupta N, San Sebastian W, et al. Gene therapy for aromatic L-amino acid decarboxylase deficiency by MR-guided direct delivery of AAV2-AADC to midbrain dopaminergic neurons. Nat Commun. 2021;12(1):42-51. https://doi.org/10.1038/s41467-021-24524-8
Golosnaya GS, Ermolenko NA, Krasnorutskaya ON, et al. CTNNB1 syndrome (CTNNB1-NDD) in a child with cerebral palsy: a case report. Russian Journal of Child Neurology. 2023;18(1):46-51. (In Russ.). https://doi.org/10.17650/2073-8803-2023-18-1-46-51
Komantsev VN, Mollaeva KYu, Umakhanova ZR. Clinical and electroneuromyographic algorithm for topical diagnosis of muscular hypotension syndrome in young children. Doktor.Ru. 2020;19(9):20-26. (In Russ.). https://doi.org/10.31550/1727-2378-2020-19-9-20-26
Detskii tserebral’nyi paralich: effektivnye sposoby bor’by s dvigatel’nymi narusheniyami. Pod red. Umnova V.V. Spb.: Desyatka; 2013. (In Russ.).
Kozhevnikova VT. Sovremennye tekhnologii fizicheskoi reabilitatsii bol’nykh s posledstviyami perinatal’nogo porazheniya nervnoi sistemy. M.: Madzhenta; 2013. (In Russ.).
Nemkova SA, Zavadenko NN, Suvorinova NYu. Application cortexin complex neurorehabilitation in children. Rossiiskii Vestnik Perinatologii i Pediatrii. 2015;2:37-44. (In Russ.).
Gomazkov OA. Cortexin: molecular mechanisms and target neuroprotective activity. Zhurnal Nevrologii i Psikhiatrii im. S.S. Korsakova. 2015;115(8):99-104. (In Russ.). https://doi.org/10.17116/jnevro20151158199-104
Platonova TN. Using cortexin in complex treatment of diseases of the nervous system in children. Terra Medica. 2000;4:50-53. (In Russ.).
Pinelis VG, Storozhevykh T, Surin A. Neuroprotective effects of cortagen, cortexin and semax on glutamate neurotoxicity. J Peptide Sci. 2008;14(8):159-160.
Shabanov PD, Vislobokov AI. Neyronoprotektornoe action cortexin and kortagena. Obzory po Klinicheskoi Farmakologii i Lekarstvennoi Terapii. 2013;2(11):17-25. (In Russ.).
Ganstrem OK, Sorokina EG, Salykina MA, et al. Cortexin (neuroprotection at the molecular level). Neiroimmunologiya. 2010;8(1-2):40-46. (In Russ.).
Pravdukhina GP. Effect of cortexin on the structural and functional state of the interneuronal synapses of the developing cerebral cortex of white rats after intrauterine acute ischemia. Byulleten’ sibirskoi Meditsiny. 2008;2:121-124. (In Russ.).
Yakovlev AA, Gulyaeva NV. Molecular partners of Cortexin in the brain. Neirokhimiya. 2017;34(1):91-96. (In Russ.).
Kuznetsova AV, Bol’shakova LA, Babintseva AA, Stepanova OA. Efficiency cortexin in the treatment of preterm infants in a critical state due to the defeat of the central nervous system and respiratory tract perinatal origin. Nevrologicheskii Vestnik. 2008;15(3):38-41. (In Russ.).
Belousova TV, Ryazhina LA. Perinatal’nye porazheniya tsentral’noi nervnoi sistemy u novorozhdennykh: Metodicheskie rekomendatsii. SPb.: OOO «Natis Print»; 2010. (In Russ.).
Koval’chuk-Kovalevskaya OV, Evsyukova II. The use of neuroprotection in the treatment of newborn children with functional development of the central nervous system. Pediatriya. 2012;91;6:129-134. (In Russ.).
Khlynina TN, Gorev VV, Kondrat’eva EI, et al. Application cortexin with perinatal lesions of the central nervous system in preterm infants. Voprosy Sovremennoi Pediatrii. 2006;5(1):616-619. (In Russ.).
Red’ko EK, Moroz TD, Paskaryk EYu, Tresnitskaya YuV. Opyt primeneniya korteksina u nedonoshennykh novorozhdennykh s perinatal’nym porazheniem tsentral’noi nervnoi sistemy. Sumy: SumGU; 2009. (In Russ.).
Kleimenova IS. Effektivnoe lechenie narushenii razvitiya psikho-nevrologicheskikh funktsii u detei rannego vozrasta. V kn.: Neiroprotektsiya pri ostroi i khronicheskoi nedostatochnosti mozgovogo krovoobrashcheniya. SPb.: Nauka; 2007. (In Russ.).
Gromada NE. K lecheniyu otdalennykh posledstvii perinatal’nogo porazheniya TsNS. V kn.: Neiroprotektsiya pri ostroi i khronicheskoi nedostatochnosti mozgovogo krovoobrashcheniya. SPb.: Nauka; 2007. (In Russ.).
Kovtun OP, Chashchina ON. Evaluation of complex therapy of premature infants suffering from retinopathy and perinatal damage to the central nervous system. Vestnik Ural’skoi Meditsinskoi Akademicheskoi Nauki. 2007;4:94-97. (In Russ.).
Isanova VA, Ismagilov MF. Cortexin in the complex rehabilitation of patients with infantile cerebral palsy. Nevrologicheskii Vestnik. 2008;15(4):125-127. (In Russ.).
Studenikin VM, Pak LA, Shelkovskii VI, et al. Application cortexin in Child Neurology: Experience and Prospects. Farmateka. 2008;14:23-29. (In Russ.).
Ivannikova NV, Esaulova IV, Avdonina VYu. Cortexin in complex rehabilitation and rehabilitation of children with disabilities. M.: Terra Medica. 2004;7-8. (In Russ.).
Ukhanova TA, Gorbunov FE, Ivanova VV. Treatment of speech disorders in children’s cerebral palsy by combining reflexotherapy with cortexin. Zhurnal Nevrologii i Psikhiatrii im. S.S. Korsakova. 2011;111(8):19-22. (In Russ.).

Close metadata